Skip to main content

News and blog posts

28
Aug 2025

Intra-DRG list updated in France

In August 2025, the updated version of the intra-DRG list was published in France. One new device was registered in the neurovascular field (BOBBY balloon guide catheter). Another change concerned the renewal of the registration for one device.
27
Aug 2025

Updates of the Belgian List of reimbursable devices in August 2025

In August 2025, Belgian National Institute for Health and Disability Insurance (INAMI/RIZIV) updated the List of implants and invasive medical devices. A new sub-chapter for bone conduction hearing systems with nine material codes was introduced. One new material code was added for bipolar radiofrequency endometrial ablation. Two new Nominative lists for brand-specific bone conduction hearing systems were also published. Changes will come into force on September 1, 2025.
27
Aug 2025

Health Economic Publication Digest: Potential Impact of EQ-5D-5L Mapping Function Recently Recommended by the National Institute for Health and Care Excellence on Utility Values and Decision Making

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Maervoet et al. compared the newly recommended NICE Decision Support Unit (DSU) mapping function for EQ-5D-5L to EQ-5D-3L with the previously endorsed van Hout Crosswalk.
26
Aug 2025

Three more health apps have obtained reimbursement in Germany since February 2025

Between early March 2025 and late August 2025, three more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, 58 health apps are currently available in the DiGA Directory, and fourteen health apps were delisted from the Directory.
26
Aug 2025

Publication Digest: Research Method, Conduct, and Reporting Considerations for Improving the Quality of Non-Hypothesis-Evaluating Treatment Effectiveness Analyses Using Real-World Data: An ISPOR Special Interest Group Report

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Barrette et al. examined how existing real-world evidence (RWE) guidance for hypothesis-evaluating treatment effectiveness (HETE) studies applies to non-HETE analyses.
25
Aug 2025

Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better. From the week of August 25th, we plan to work on 23 projects. Review the complete list of planned activities in this post.
25
Aug 2025

EU HTA Publication Digest: Classification grid and evidence matrix for evaluating digital medical devices under the European Union landscape

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, Boers et al. introduced the Common European Classification Grid (CEUGrid-DMD) and an Evidence Matrix to harmonize the evaluation of digital medical devices (DMDs) across the EU.
22
Aug 2025

The 2026 version of the Swiss CHOP code classification was published

On July 31, 2025, the Swiss Federal Statistics Office (UFS) released the systematic version of the Swiss classification of surgical interventions (CHOP) for 2026. The CHOP classification is now available in German and will come into force on January 1, 2026. Multiple new procedure codes were introduced in various fields, including the cardiovascular, ENT, extracorporeal treatments, interventional radiology, nephrology and urology, orthopedics, peripheral vascular, and radionucleide therapy.
21
Aug 2025

Sustainability Publication Digest: The carbon footprint of cataract surgery pathways in England: an observational study using administrative data

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Sustainability Publications Digest. In a recent publication, van-Hove et al. analysed the carbon footprint of cataract surgery in England and the potential impact of adopting the NHS “Getting It Right First Time” (GIRFT) High Volume Low Complexity (HVLC) pathway.